Bank Of New York Mellon Corp current report, 13 October 2008

Business Context and Reporting Period

Company: The Bank of New York Mellon Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: October 13, 2008
Event Date: October 13, 2008 (TARP agreement); October 14, 2008 (FDIC program announcement)

Key Financial Metrics

This filing does not report standard operating metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial disclosure relates to a capital transaction:

  • Capital Raise: Agreed to issue preferred stock and warrants to the U.S. Treasury for an aggregate purchase price of $3 billion under the TARP Capital Purchase Program.

Material Changes

The filing discloses two significant material events regarding liquidity and capital structure:

  • TARP Participation: On October 13, 2008, the Company agreed to participate in the U.S. Treasury's Troubled Asset Relief Program (TARP) Capital Purchase Program.
  • FDIC Eligibility: On October 14, 2008, the Company and its U.S. bank subsidiaries were confirmed as eligible institutions under the FDIC's new Temporary Liquidity Guarantee Program.

Guidance, Outlook, and Risks

Management Commentary: The filing is a factual disclosure of regulatory program participation and does not contain forward-looking guidance, earnings outlook, or specific management commentary on future performance.

Risks and Contingencies: The filing implies significant liquidity and capital market risks necessitating government intervention. The terms of the TARP participation are governed by the U.S. Treasury's term sheet, and the FDIC program details are subject to the FDIC's Financial Institution Letter.

Investor Verification Checklist

  • Verify the specific terms of the preferred stock and warrants issued to the U.S. Treasury via the Treasury's term sheet.
  • Confirm the specific coverage and limitations of the FDIC Temporary Liquidity Guarantee Program for the Company's subsidiaries.
  • Review subsequent filings for the actual closing date and final capital injection amount.
  • Assess the impact of the $3 billion capital raise on existing shareholder dilution and earnings per share.